Expected earnings - Aligos Therapeutics Inc.
Source: US Earnings Reports
Aligos Therapeutics Inc. (ALGS) is expected to report $-2.35 for Q2 2025
Aligos Therapeutics Inc.
NASDAQ: ALGS
ALGS Trading
4.49% G/L:
$7.68 Last:
16,592 Volume:
$7.5615 Open:
ALGS Latest News
March 05, 2026 08:00:00 am
Aligos Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2025 Financial Results
February 26, 2026 08:00:00 am
Aligos Therapeutics to Announce 4th Quarter 2025 Financial Results on March 5, 2026
February 23, 2026 08:00:00 am
Aligos Therapeutics Presents Positive Data at the Conference on Retroviruses and Opportunistic Infections (CROI)
ALGS Stock Data
$44,428,862
3,138,388
3.86%
16
N/A
Biotechnology & Life Sciences
Healthcare
US
South San Francisco
